About CTS Capital
CTS Capital is a venture capital firm founded in 2017. It is primarily based out of Chaoyang, China. As of Apr 2026, CTS Capital is an active investor, having invested in 24 companies, with 2 new investments in the last 12 months. It primarily invests in Series A round in China based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and HealthTech. Most recently it participated in the $***** Seed round of RobotGym Overall, CTS Capital portfolio has seen 1 unicorn, 1 IPO and 1 acquisition, namely iKang Guobin, United Imaging Healthcare and Tianjing Biological. A lot of funds co-invest with CTS Capital, with names like BridgeOne Capital sharing a substantial percentage of its portfolio.Key Metrics
Portfolio Count
Portfolio Sectors
Rounds of Entry
Series A, Seed & 3 more
Portfolio IPOs
Portfolio Acquisitions
Portfolio Unicorns
Portfolio Soonicorns
CTS Capital's List of Top Investments
CTS Capital has a portfolio of 24 companies, one of which is a Unicorn. Their most notable investments are in IntellectiveBio and Cornerstone Robotics.Their portfolio spans across China, Germany and United States. They have invested in Life Sciences, High Tech, HealthTech and 3 other sectors, across stages such as Series A, Seed and 3 more. Here is the list of top investments by CTS Capital:1. iKang Guobin
Key facts about iKang Guobin
- Founded Year: 2004
- Location: Beijing (China)
- Stage: Acquired
- Total Funding till date: $100M
- Employee Count: 869 as on Sep 30, 2026
- Investors: Goldman Sachs, EPlanet Capital and 4 Others
- Latest Funding Round: Post IPO, Feb 02, 2016, $*****
- Highlight: Acquired
Developer and manufacturer of advanced medical imaging and radiotherapy equipment. It offer high-performance digital solutions, including equipment and services, to improve diagnostic imaging and patient care outcomes.
Key facts about United Imaging Healthcare
- Founded Year: 2011
- Location: Shanghai (China)
- Valuation: $*****
- Stage: Series B
- Total Funding till date: $504M
- Employee Count: 2,588 as on Sep 30, 2026
- Investors: China Life Insurance, SDIC Innovation and 19 Others
- Latest Funding Round: Series B, 2018, $*****
- Highlight: Editors' Pick
Provider of reagents and kits for clinical research. The product portfolio of the company includes recombinant proteins, antibodies, and antibody-based kits that are used to study cellular function and human diseases. Additionally, the company also offers services in custom antibody development, protein production, and purification.
Key facts about Sino Biological
- Founded Year: 2007
- Location: Beijing (China)
- Stage: Series A
- Total Funding till date: $29.4M
- Employee Count: 285 as on Sep 30, 2026
- Investors: Qiming Venture Partners, CTS Capital and 1 Other
- Latest Funding Round: Series A, Jul 06, 2017, $*****
Developer of immuno-oncology drugs for treating cancer and autoimmune diseases. The company has developed an in-house platform to generate monoclonal antibodies through hybridoma and phage display technologies. The company's product line include Olamkicept used for treating ulcerative colitis, TJ202 for Multiple myeloma / Autoimmune diseases, TJ101 for pediatric growth hormone deficiency, TJ301 for Ulcerative colitis / Auto-immune disease, Enoblituzumab for T cell activation combined with tumor-killing, etc.
Key facts about Tianjing Biological
- Founded Year: 2014
- Location: Shanghai (China)
- Stage: Public
- Total Funding till date: $380M
- Employee Count: 93 as on Aug 31, 2026
- Investors: Perceptive Advisors, GIC and 19 Others
- Latest Funding Round: Post IPO, Feb 11, 2024, $*****
- Highlight: Public
Developer of medical robotic devices for rehabilitation and surgery. The company is developing medical robotic devices and equipment which enable physicians to improve the efficiency of surgical operations.
Key facts about Cornerstone Robotics
- Founded Year: 2019
- Location: Hong Kong (China)
- Stage: Series D
- Total Funding till date: $459M
- Employee Count: 63 as on Aug 31, 2026
- Investors: EQT, New World Development and 16 Others
- Latest Funding Round: Series D, Nov 10, 2025, $*****
- Highlight: Editors' Pick
CTS Capital's Year-on-Year Investment Trends
CTS Capital has invested in 24 companies over the last 5 years, with an average of 1 new investment annually in the last 5 years. As of Apr 2026, it has made 2 investments in this year. Its most recent first time investment was in RobotGym.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 2 | 0 | 2 |
2025 | 0 | 0 | 0 |
2024 | 0 | 0 | 0 |
2023 | 2 | 0 | 2 |
2022 | 3 | 0 | 3 |
2021 | 2 | 0 | 2 |
CTS Capital's Investments by Stage
CTS Capital has made 3 investments in Series A stage with an average round size of $31.5M, 2 investments in Seed stage, 2 investments in Series C stage with an average round size of $92.2M, 1 investment in Angel stage with an average round size of $21.6M and 1 investment in Series B stage with an average round size of $100M.Stage of entry | No. of Investments |
|---|---|
Series A | 3 |
Seed | 2 |
Series C | 2 |
Angel | 1 |
Series B | 1 |
Note: We have considered here, only first round of investments
CTS Capital's Investments by Sector
CTS Capital has a diverse portfolio, with companies operating in the Life Sciences, High Tech, Artificial Intelligence - Industry Applications, Chemicals and Materials and HealthTech. Notably, it has invested in 20 Tech companies, 18 Enterprise (B2B) companies, 5 Tech hardware companies and at least 3 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
Life Sciences | 6 |
High Tech | 2 |
Artificial Intelligence - Industry Applications | 1 |
Chemicals and Materials | 1 |
HealthTech | 1 |
Others | 3 |
Note: We have considered here, only first round of investments
CTS Capital's Investments by Geography
CTS Capital has made most investments in China (7), followed by Germany where it has made 1 investment.Country | No. of Investments |
|---|---|
China | 7 |
Germany | 1 |
United States | 1 |
Note: We have considered here, only first round of investments
CTS Capital's recent investments
CTS Capital has made 2 investments in 2026 so far - RobotGym and Gestala.Here are the most recent investments by CTS Capital:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Apr 2026 | Germany | Seed | 4607 | ||
Mar 11, 2026 | China | Angel | 6218 | [+5] | |
Jul 07, 2023 | China | Series C | 8594 | [+6] | |
Mar 09, 2023 | China | Seed | 5437 | [+1] | |
Sep 05, 2022 | China | Series A | 6242 |
Unicorns in CTS Capital's Portfolio
CTS Capital has 1 unicorn in its portfolio - United Imaging Healthcare. The most recent unicorn in their portfolio is United Imaging Healthcare which became a unicorn in 2018, 8 years before CTS Capital first invested in it.Here is a list of unicorns in CTS Capital's portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
64 | Developer and manufacturer of advanced medical imaging and radiotherapy equipment | 2011 | Shanghai | Series B | bwgkcnn |
IPOs and Publicly Listed companies in CTS Capital's Portfolio
1 of CTS Capital's portfolio company became public - Tianjing Biological. It got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Jan 2020 at marketcap of $104MHere are CTS Capital's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jan 17, 2020 | - | - | 5172 |
Acquired companies in CTS Capital's Portfolio
1 company from CTS Capital's portfolio has been acquired. The most recent acquisition was iKang Guobin in Mar 2018 by Yunfeng Capital for $*****.Here are CTS Capital's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Mar 12, 2018 | - | - | 4926 |
Co-investors of CTS Capital
Over the past 5 years, 60 investors have co-invested in CTS Capital's portfolio companies. This includes funds and angels.
- Invested before CTS Capital: Lilly Asia Ventures, Meituan and 9 others have invested in rounds before CTS Capital. There are 2 companies where Lilly Asia Ventures has invested before CTS Capital and 1 company where Meituan has invested before CTS Capital.
- Top Co-investors of CTS Capital: 33 investors entered a company along with CTS Capital. These include investors like BridgeOne Capital (1 company).
- Invested after CTS Capital: A total of 16 investors have invested in CTS Capital's portfolio after their investments. Top Investors include EQT (1 company), Alpha JWC Ventures (1 company) and Innovation and Technology Fund (1 company).
Recent News related to CTS Capital
•
•
D3 Bio Secures $108 Million in Series B Financing to Advance Global Clinical ProgramsPR Newswire•Dec 10, 2025•Temasek, IDG Capital, D3 Bio, HSG and 5 others
•
Suzhou Meichuang secures over ¥100 million in A+ funding for medical implant innovation, advised by Kaicheng Capital.PencilNews•Jan 15, 2025•Suzhou MedEdge Medical, Sequoia Capital, CTS Capital, WinX Capital and 1 other
•
Qingsong Capital completed the latest round of investment in Xingshun New MaterialsJinglingshuju•Dec 18, 2024•CTS Capital, Sd-Xingshun
•
AutoAGENTS completes tens of millions of yuan angel round financing-Investor NetworkInvestorscn•Dec 26, 2023•Sinovation Ventures, mesonstechnologies.com, CTS Capital
•
Surgical Robot Company Cornerstone Completed A New Round of Financing of CNY 800MEqualOcean•Jul 07, 2023•Cornerstone Robotics, BridgeOne Capital, Lenovo Capital and Incubator Group, CTS Capital and 4 others
•
IntellectiveBio Exceeds $74M in Round-C FinancingPandaily•Aug 05, 2022•IntellectiveBio, Gaorong Capital, FUHO Capital Management, CTS Capital and 1 other
•
New drug research and development company Chengyi Biotechnology completes a new round of financing exceeding 100 million yuanPEdaily•Mar 16, 2021•Chengyi Pharmaceutical, Oriza Holdings, Delos Capital Partners, CTS Capital and 2 others
